Assignee
GLENMARK PHARMACEUTICALS LTD
IN·29 granted patents·47 pending applications·116 citations·filing 2003–2025
Top patents by PatentIndex Score
76 records- 0192US9370483B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Jun 21, 2016·8 cites·21 claims
- 0290US9078923B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 14, 2015·24 cites·21 claims
- 0384US7230002B2Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereofGLENMARK PHARMACEUTICALS LTD·Filed 2005·Granted Jun 12, 2007·6 cites·29 claims
- 0481US7649096B2Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamideGLENMARK PHARMACEUTICALS LTD·Filed 2006·Granted Jan 19, 2010·8 cites·9 claims
- 0581US7238725B2Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing themGLENMARK PHARMACEUTICALS LTD·Filed 2003·Granted Jul 3, 2007·21 cites·45 claims
- 0679US9695159B2Process for preparation of canagliflozinGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Jul 4, 2017·3 cites·9 claims
- 0777US12514996B2Metered dose inhalers of fluticasone or an ester thereofGLENMARK PHARMACEUTICALS LTD·Filed 2024·Granted Jan 6, 2026·0 cites·10 claims
- 0877US9670160B2Process for the preparation of tofacitinib and intermediates thereofGLENMARK PHARMACEUTICALS LTD·Filed 2013·Granted Jun 6, 2017·4 cites·20 claims
- 0976US2026091182A1Metered dose inhalers of fluticasone or an ester thereofGLENMARK PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1071US10548907B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Feb 4, 2020·1 cites·32 claims
- 1170US2025064735A1Container system and pharmaceutical foam composition comprising betamethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1267US12514995B2Metered dose inhalers of fluticasone or an ester thereofGLENMARK PHARMACEUTICALS LTD·Filed 2022·Granted Jan 6, 2026·0 cites·7 claims
- 1367US7312329B2Process for the preparation of pyrimidine derivativesGLENMARK PHARMACEUTICALS LTD·Filed 2004·Granted Dec 25, 2007·11 cites·55 claims
- 1466US12502489B1Metered dose inhaler for ipratropium bromide solutionGLENMARK PHARMACEUTICALS LTD·Filed 2024·Granted Dec 23, 2025·0 cites·22 claims
- 1566US10106483B2Process for preparation of azelaic acidGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Oct 23, 2018·1 cites·12 claims
- 1665US2026077140A1Metered dose inhaler for ipratropium bromide solutionGLENMARK PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1762US2011105448A1Stable Topical Formulation Comprising VoriconazoleGLENMARK PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 1861US7291745B2Process for the preparation of perindoprilGLENMARK PHARMACEUTICALS LTD·Filed 2006·Granted Nov 6, 2007·2 cites·15 claims
- 1959US2021196631A1Container system and pharmaceutical foam composition comprising betamethasoneGLENMARK PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2056USD795414SInhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Aug 22, 2017·11 cites·1 claims
- 2156US2008118555A1Stable pharmaceutical composition containing desloratadineGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 2255US10646500B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted May 12, 2020·0 cites·15 claims
- 2355US10357622B2Dry powder inhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 23, 2019·1 cites·17 claims
- 2455USD797920SInhalerGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Sep 19, 2017·10 cites·1 claims
- 2552US7414143B2Process for the preparation of 4,4-dimethyl-6-ethynylthiochromanGLENMARK PHARMACEUTICALS LTD·Filed 2005·Granted Aug 19, 2008·0 cites·20 claims
- 2651US2019275269A1Dry Powder InhalerGLENMARK PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2751US2008014263A1Amorphous eprosartan mesylate and process for the preparation thereofGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 2850US2008071094A1Process for the preparation of perindoprilGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 2950US2008249120A1Pharmaceutical compositionsGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3048US9776985B2Process for preparation of alogliptinGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Oct 3, 2017·0 cites·11 claims
- 3148US2007275052A1Pharmaceutical compositions containing sterol inhibitorsGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3246US2007299123A1Amorphous frovatriptan succinate and process for the preparation thereofGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 3345US6963002B2Process for the preparation of 4,4-dimethyl-6-ethynylthiochromanGLENMARK PHARMACEUTICALS LTD·Filed 2004·Granted Nov 8, 2005·0 cites·23 claims
- 3444US2007105927A1Amorphous rizatriptan benzoateGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 3544US2004185097A1Controlled release modifying complex and pharmaceutical compositions thereofGLENMARK PHARMACEUTICALS LTD·Filed 2004·Application pending·0 cites
- 3644US2009105350A1Process for the preparation of atovaquoneGLENMARK PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 3742US9499475B2Process for the preparation of arformoterol or salt thereofGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Nov 22, 2016·0 cites·11 claims
- 3842US2006111343A1Oxcarbazepine dosage formsGLENMARK PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 3942US2007112055A1Crystalline forms of almotriptan and processes for their preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4042US2006281800A1Polymorphic form of olmesartan and process for its preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4142US2008014280A1Amorphous pregabalin and process for the preparation thereofGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 4242US2020345671A1Topical pharmaceutical composition of adapalene and minocyclineGLENMARK PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 4341US2007238881A1Process for the preparation of tazarotene intermediates and use thereof for the preparation of tazaroteneGLENMARK PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 4440US9840456B2Process for preparation of dimethyl fumarateGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Dec 12, 2017·0 cites·8 claims
- 4540US9663505B2Process for the preparation of rivaroxabanGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted May 30, 2017·0 cites·11 claims
- 4640US2007135472A1Novel crystalline forms of desloratadine and processes for their preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4740US2006084826A1Process for the preparation of naphthylmethylamine derivativesGLENMARK PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 4840US2007105828A1Novel polymorph form M of mifepristone and process for its preparationGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 4940US2005249757A1Pharmaceutical cream formulationsGLENMARK PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 5040US2006189670A1Process for the preparation of anastrozole and intermediates thereofGLENMARK PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GLENMARK PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →